Systemic sclerosis & Raynaud's

Development of a measuring app for systemic sclerosis-related digital ulceration (SALVE: Scleroderma App for Lesion VErification)

Rheumatology (Oxford)Published Feasibility and measurement development study

Authors' conclusion

Even patients with significant hand disability were able to use the app. Automated measurement of finger lesions could be valuable as an outcome measure in clinical trials.

Study context

Population
Patients with SSc-related digital lesions19 completed
Participants
25 patients
Comparison
Manual vs automated measurement of SSc-related digital lesion area
Outcome
Lesion area
Follow-up
Day 1
Methodological detailssmartphone app, daily photographs for 30 days, manual and automated (machine learning) lesion measurement
  • Smartphone app
  • Daily photographs for 30 days
  • Manual and automated (machine learning) lesion measurement

Main finding

As reported in the abstract

GroupValueDecrease per dayDecrease over 30 days
Manualmean 11.6 (SD 16.0) mm²0.08 mm²2.4 mm²
Automatedmean 13.9 (SD 16.7) mm²0.1 mm²3.0 mm²

Value

Manualmean 11.6 (SD 16.0) mm²
Automatedmean 13.9 (SD 16.7) mm²

Decrease per day

Manual0.08 mm²
Automated0.1 mm²

Decrease over 30 days

Manual2.4 mm²
Automated3.0 mm²
Correlation of average gradients of manual and automated measurements over 30 days (r)
0.81
Manual measurements on average lower than automated ones, with wide limits of agreement
40%

Further findings

Baseline Pain score

Mean (SD) baseline Pain score
5.7 (2.4)
  • Indicating high lesion- and disease-related morbidity

Baseline Hand Disability in Systemic Sclerosis-Digital Ulcers (HDISS-DU)

Mean (SD) baseline HDISS-DU
2.2 (0.9)
  • Indicating high lesion- and disease-related morbidity

Images used in the analysis

Total images used
506
Mean (SD) number of used images per lesion
18.7 (8.3)

Original publication

Development of a measuring app for systemic sclerosis-related digital ulceration (SALVE: Scleroderma App for Lesion VErification). Rheumatology (Oxford). Published 19 July 2024. doi:10.1093/rheumatology/keae371

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.